United States Home Infusion Market will reach US$ 20.6 Billion by 2027. Industry Trends, Growth, Insight, Outlook, Impact of Inflation, Company Analysis, Global Forecast 2023-2027
United States Home Infusion Market will reach US$ 20.6 Billion by 2027 according to the publisher. Home infusion is a clinically suitable treatment option for patients with a wide array of chronic and acute conditions, ranging from bacterial infections to progressively complex conditions like immune deficiencies, nutrition support, bleeding disorders, and late-stage heart failure. Home infusion can afford patients liberty and better quality of life since it is offered in the comfort of the patient's home, effectively fitting their needs. It also gives better outcomes, provides enhanced safety, and is cost-effective.
The increasing geriatric population susceptible to chronic diseases and rising prevalence of urinary tract infections will boost the market growth:
The rapidly growing old-aged population in the United States is one of the main drivers of market growth. For instance, according to data issued by the United States Department of Health and Human Services, there are more than 49.2 million individuals above 65 years of age across the country. Moreover, the number of graying Americans has risen by around 33% over the past decennium. Therefore, as home infusion therapy aids in managing chronic conditions of the elderly populace, the market will witness significant growth in the future.
According to a recent news article, urinary tract infections contribute to about 6 million patient visits to physicians each year in the United States Thus, a large patient pool requiring home infusion therapy will generate high demand over the analyzed period. In addition, the acceptance of new technologies in the home infusion therapy market will support the industry's growth.
United States Home Infusion Market is expected to grow with a CAGR of 7.88% from 2022 to 2027
Amongst other segments, an infusion pump holds a significant share in 2022. This can be attributed to their efficiency and increasing use in delivering medications, nutrition, and other required fluids in required amounts. Needleless connectors is anticipated to be the fastest-growing segment over the forecast period owing to various benefits, such as higher protection against needlestick injuries and less risk of bacterial contamination. In addition, needleless connectors reduce the risk of Healthcare Associated Bloodstream Infections. Owing to these features, the demand for needleless connectors is predicted to augment over the forecast period.
Indication Insights:
Based on Indication, the U.S. home infusion therapy market is categorized into Anti-infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Parenteral Nutrition, Immunoglobulins, and Others. Hydration therapy provides several benefits, such as boosting immunity and reduced recovery time. It also improves cognitive functions, flushes toxins from the body, is efficient, it tends to strengthen joint, skin, and muscle health.
COVID-19 Impact on U.S. Home Infusion Therapy Market:
The COVID-19 pandemic has positively impacted the Industry. The U.S. Key players reported a significant growth in revenues from services, devices, and drugs, owing to the considerable increase in patients receiving infusion therapy at home during COVID-19 restrictions. For instance, Option Care Health, Inc. generated USD 3,302.6 million in 2020 and witnessed a 30.1% increase in its revenue in 2020 compared to 2019. The growth was attributable to increased demand for its home infusion therapy services.
Furthermore, In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule broadening coverage for home infusion Durable Medical Equipment (DME), specifically for external infusion pumps, to increase access to home infusion drugs. Moreover, with the COVID-19 outbreak, home-infusion solutions have become more critical than ever, allowing patients to remain in their homes, thereby decreasing the risk of exposure. Hence, various local infusion service providers witnessed a surge in demand for home-based services.
Key Players:
CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings are the leading competitors in the U.S. home infusion therapy market. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.
The publisher's latest report “U.S. Home Infusion Therapy Market, Forecast By Product (Home Infusion Device, Home Infusion Drugs, Home Infusion Services), Product Type (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Indication (Anti-infective, Chemotherapy, HydrationTherapy, EnteralNutrition, Parenteral Nutrition, Immunoglobulins, Others), Zone (East North Central, West South Central, South Atlantic, North East, East South Central, West North Centre, Pacific Central, Mountain States,) Companies (CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, InfuSystems Holdings)” provides a detailed analysis of U.S. Home Infusion Therapy Industry.
Product - The market has been studied from 3 viewpoints:
1. Home Infusion Device
2. Home Infusion Drugs
3. Home Infusion Services
Product Type - The market has been studied from 4 viewpoints:
1. Infusion Pump
2. Intravenous Sets
3. IV Cannulas
4. Needleless Connectors
Indication - The market has been studied from 7 viewpoints:
1. Anti-infective
2. Chemotherapy
3. Hydration Therapy
4. Enteral Nutrition
5. Parenteral Nutrition
6. Immunoglobulins
7. Others
Zone - The market has been studied from 8 viewpoints:
1. East North Central
2. West South Central
3. South Atlantic
4. North East
5. East South Central
6. West North Centre
7. Pacific Central
8. Mountain States
Company Insights:
- Overview
- Initiatives/Recent Developments
- Financial Insight
Companies Covered:
1. CVS Health
2. Becton, Dickinson and Company
3. Smith & Nephew plc
4. Terumo Corporation
5. ICU Medical
6. Moog
7. InfuSystems Holdings
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Home Infusion Therapy Market
6. Market Share - United States Home Infusion Therapy Market
6.1 By Product
6.2 By Product Type
6.3 By Indication
6.4 By Zone
7. Product - United States Home Infusion Therapy Market
7.1 Home Infusion Device
7.2 Home Infusion Drugs
7.3 Home Infusion Services
8. Product Type - United States Home Infusion Therapy Market
8.1 Infusion Pump
8.2 Intravenous Sets
8.3 IV Cannulas
8.4 Needleless Connectors
9. Indication - United States Home Infusion Therapy Market
9.1 Anti-infective
9.2 Chemotherapy
9.3 Hydration Therapy
9.4 Enteral Nutrition
9.5 Parenteral Nutrition
9.6 Immunoglobulins
9.7 Others
10. Zone - United States Home Infusion Therapy Market
10.1 East North Central
10.2 West South Central
10.3 South Atlantic
10.4 North East
10.5 East South Central
10.6 West North Centre
10.7 Pacific Central
10.8 Mountain States
11. Key Players
11.1 CVS Health
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue
11.2 Becton, Dickinson and Company
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue
11.3 Smith & Nephew plc
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Revenue
11.4 Terumo Corporation
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Revenue
11.5 ICU Medical
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Revenue
11.6 Moog
11.6.1 Overview
11.6.2 Recent Development
11.6.3 Revenue
11.7 InfuSystems Holdings
11.7.1 Overview
11.7.2 Recent Development
11.7.3 Revenue
List of Figures
Figure 01: United States - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 02: United States - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 03: Product - Home Infusion Device Market (Million US$), 2017 - 2022
Figure 04: Product - Forecast for Home Infusion Device Market (Million US$), 2023 - 2027
Figure 05: Product - Home Infusion Drugs Market (Million US$), 2017 - 2022
Figure 06: Product - Forecast for Home Infusion Drugs Market (Million US$), 2023 - 2027
Figure 07: Product - Home Infusion Services Market (Million US$), 2017 - 2022
Figure 08: Product - Forecast for Home Infusion Services Market (Million US$), 2023 - 2027
Figure 09: Product Type - Infusion Pump Market (Million US$), 2017 - 2022
Figure 10: Product Type - Forecast for Infusion Pump Market (Million US$), 2023 - 2027
Figure 11: Product Type - Intravenous Sets Market (Million US$), 2017 - 2022
Figure 12: Product Type - Forecast for Intravenous Sets Market (Million US$), 2023 - 2027
Figure 13: Product Type - IV Cannulas Market (Million US$), 2017 - 2022
Figure 14: Product Type - Forecast for IV Cannulas Market (Million US$), 2023 - 2027
Figure 15: Product Type - Needleless Connectors Market (Million US$), 2017 - 2022
Figure 16: Product Type - Forecast for Needleless Connectors Market (Million US$), 2023 - 2027
Figure 17: Indication - Anti-infective Market (Million US$), 2017 - 2022
Figure 18: Indication - Forecast for Anti-infective Market (Million US$), 2023 - 2027
Figure 19: Indication - Chemotherapy Market (Million US$), 2017 - 2022
Figure 20: Indication - Forecast for Chemotherapy Market (Million US$), 2023 - 2027
Figure 21: Indication - Hydration Therapy Market (Million US$), 2017 - 2022
Figure 22: Indication - Forecast for Hydration Therapy Market (Million US$), 2023 - 2027
Figure 23: Indication - Enteral Nutrition Market (Million US$), 2017 - 2022
Figure 24: Indication - Forecast for Enteral Nutrition Market (Million US$), 2023 - 2027
Figure 25: Indication - Parenteral Nutrition Market (Million US$), 2017 - 2022
Figure 26: Indication - Forecast for Parenteral Nutrition Market (Million US$), 2023 - 2027
Figure 27: Indication - Immunoglobulins Market (Million US$), 2017 - 2022
Figure 28: Indication - Forecast for Immunoglobulins Market (Million US$), 2023 - 2027
Figure 29: Indication - Others Market (Million US$), 2017 - 2022
Figure 30: Indication - Forecast for Others Market (Million US$), 2023 - 2027
Figure 31: East North Central - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 32: East North Central - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 33: West South Central - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 34: West South Central - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 35: South Atlantic - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 36: South Atlantic - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 37: North East - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 38: North East - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 39: East South Central - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 40: East South Central - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 41: West North Centre - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 42: West North Centre - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 43: Pacific Central - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 44: Pacific Central - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 45: Mountain States - Home Infusion Therapy Market (Million US$), 2017 - 2022
Figure 46: Mountain States - Forecast for Home Infusion Therapy Market (Million US$), 2023 - 2027
Figure 47: CVS Health - Global Revenue (Million US$), 2017 - 2022
Figure 48: CVS Health - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 49: Becton, Dickinson and Company - Global Revenue (Million US$), 2017 - 2022
Figure 50: Becton, Dickinson and Company - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 51: Smith & Nephew plc - Global Revenue (Million US$), 2017 - 2022
Figure 52: Smith & Nephew plc - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 53: Terumo Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 54: Terumo Corporation - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 55: ICU Medical - Global Revenue (Million US$), 2017 - 2022
Figure 56: ICU Medical - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 57: Moog - Global Revenue (Million US$), 2017 - 2022
Figure 58: Moog - Forecast for Global Revenue (Million US$), 2023 - 2027
Figure 59: InfuSystems Holdings - Global Revenue (Million US$), 2017 - 2022
Figure 60: InfuSystems Holdings - Forecast for Global Revenue (Million US$), 2023 - 2027
List of Tables
Table 01: United States - Home Infusion Therapy Market Share by Product (Percent), 2017 - 2022
Table 02: United States - Forecast for Home Infusion Therapy Market Share by Product (Percent), 2023 - 2027
Table 03: United States - Home Infusion Therapy Market Share by Product Type (Percent), 2017 - 2022
Table 04: United States - Forecast for Home Infusion Therapy Market Share by Product Type (Percent), 2023 - 2027
Table 05: United States - Home Infusion Therapy Market Share by Indication (Percent), 2017 - 2022
Table 06: United States - Forecast for Home Infusion Therapy Market Share by Indication (Percent), 2023 - 2027
Table 07: United States - Home Infusion Therapy Market Share by Zone (Percent), 2017 - 2022
Table 08: United States - Forecast for Home Infusion Therapy Market Share by Zone (Percent), 2023 - 2027
Companies Mentioned
- CVS Health
- Becton, Dickinson and Company
- Smith & Nephew plc
- Terumo Corporation
- ICU Medical
- Moog
- InfuSystems Holdings
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
